InvestorsHub Logo
icon url

circuitcity

05/23/20 1:09 PM

#275803 RE: marjac #275800

Fully agree. This line of thinking relate to amrn current inactive promotion. How long are they planing to do this? Until appeal, that is initial thought I guess. What if the outcome is unclear because of remanding to dc or anything else, are they going to defer promotion forever? In that case, they may as well just say bye to us market.

BO is ultimate solution. I just don’t see any benefits waiting it longer, except mgmt can’t milk any longer.
icon url

HinduKush

05/23/20 1:20 PM

#275812 RE: marjac #275800

Even more important than winning the appeal is selling the company, and not risking the outcome of the Appeal. Singer could write the best briefs, and orally argue with perfection, but still lose, or win a remand where this case and the accompanying FUD continues indefinitely.

People need to understand that even winning the appeal, while real nice, is not a magic entry into the promised land of Amarin prosperity, while a loss is catastrophic. The only surefire exit strategy that benefits the shareholders at this point, is the sale of the company, sooner, rather than later.



All sound statements but the exit door for settlement I fear has closed. There is no pathway to settlement by vacatur that can seal the entry of other generic challengers with certainty. Hikma/Reddys have hit a lucky break with a potty Judge Du-zy, and they will ride the play for all they can. no amount of logic about wasted building of market by Amrn for them etc will hold water. It is in their nature and they will follow suit. Of course if Amrn could find a buyer BP we know that under current uncertainties the shareholders would be cheated in acquisition price.
The more I see of our lot as shareholders, the more I feel Singer is now at the lead of our Charge of the Light Brigade: "Ours not to reason why.."

Was there a man dismay’d?
Not tho’ the soldier knew
Some one had blunder’d:
Theirs not to make reply,
Theirs not to reason why,
Theirs but to do and die:
Into the valley of Death
Rode the six hundred.
Alfred Lord Tennyson

PS Want some more good news? read this from the investorvillage board:
++Hikma Pharmaceuticals (LSE: HIK) today announced an exclusive license, supply and distribution agreement between its wholly-owned subsidiary Hikma Pharmaceuticals International and Beijing Sciecure Pharmaceutical, a leading Chinese company that researches, develops and manufactures high-quality pharmaceutical products for global markets++

icon url

postes

05/23/20 1:24 PM

#275816 RE: marjac #275800

Marjac..I think AMRN is in better hands with BP ( I don't own AMRN for a buyout ) or with competent management...a buyout would depend on a BP risk appetite for buying AMRN at a price that values the USA assets discounted in all likelihood more than JT/AMRN are welling to accommodate...if AMRN and BP could not agree on a price when there was less uncertainty and the litigation could have been in BP's hands I think it unlikely now.
At this point I would love to move on..I agree with you it is far from certainty we will be guided by current management in a responsible and profitable manner after we win appeal...the tragedy here is the wasting of such a fine product to the consumer and potential for shareholders...EU is a whole new subject...AMRN should seriously consider selling EU and rest of world and keeping US
untill after win.
JT comments on EU gia are paramount to him being to greedy. We are going 3 steps back and 1 step forward and the cliff behind us in in clear view.
icon url

FlyFishingStocks

05/23/20 1:46 PM

#275826 RE: marjac #275800

Totally agree and was hoping for this to occur until yesterday’s bomb blew up the odds of that happening anytime soon.
icon url

MateoPaisa

05/23/20 2:21 PM

#275846 RE: marjac #275800

Because this case is being taken de novo, doesn’t a remand possibility disappear?
icon url

MontanaState83

05/23/20 6:16 PM

#275897 RE: marjac #275800

Marjac - Yes!!! I don’t think JT gets it though